These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 28209667)
1. Should family physicians prescribe medication for obesity? YES. Bourns L; Shiau J Can Fam Physician; 2017 Feb; 63(2):102-103. PubMed ID: 28209667 [No Abstract] [Full Text] [Related]
2. Should family physicians prescribe medication for obesity? NO. Shaw E Can Fam Physician; 2017 Feb; 63(2):103-105. PubMed ID: 28209668 [No Abstract] [Full Text] [Related]
3. [Pharmacotherapy for obesity]. Bruun JM Ugeskr Laeger; 2016 Oct; 178(44):. PubMed ID: 27808050 [TBL] [Abstract][Full Text] [Related]
4. More about orlistat. Lucas KH; Kaplan-Machlis B Pharmacotherapy; 2000 Jul; 20(7):872-3. PubMed ID: 10907983 [No Abstract] [Full Text] [Related]
5. [Pharmacological therapy of obesity]. Pagotto U; Vanuzzo D; Vicennati V; Pasquali R G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):83S-93S. PubMed ID: 18773755 [TBL] [Abstract][Full Text] [Related]
6. Obesity drug endorsed by NICE. Wise J BMJ; 2001 Mar; 322(7287):637. PubMed ID: 11250844 [No Abstract] [Full Text] [Related]
7. Medical management of obesity: a clinical imperative? Haynes WG Curr Diab Rep; 2003 Feb; 3(1):1-3. PubMed ID: 12643140 [No Abstract] [Full Text] [Related]
8. Incorrect use of orlistat and sibutramine in clinical practice. Dahlin A; Beermann B Eur J Clin Pharmacol; 2007 Feb; 63(2):205-9. PubMed ID: 17205321 [TBL] [Abstract][Full Text] [Related]
9. Association of Pharmacological Treatments for Obesity With Weight Loss and Adverse Events: A Systematic Review and Meta-analysis. Khera R; Murad MH; Chandar AK; Dulai PS; Wang Z; Prokop LJ; Loomba R; Camilleri M; Singh S JAMA; 2016 Jun; 315(22):2424-34. PubMed ID: 27299618 [TBL] [Abstract][Full Text] [Related]
10. [Results from the observational study EPIGRAM: management of excess weight in general practice and follow-up of patients treated with orlistat]. Vray M; Joubert JM; Eschwège E; Liard F; Fagnani F; Montestruc F; Fages S; Bégaud B Therapie; 2005; 60(1):17-24. PubMed ID: 15929469 [TBL] [Abstract][Full Text] [Related]
11. Currently available drugs for the treatment of obesity: Sibutramine and orlistat. Chaput JP; St-Pierre S; Tremblay A Mini Rev Med Chem; 2007 Jan; 7(1):3-10. PubMed ID: 17266632 [TBL] [Abstract][Full Text] [Related]
12. Effectiveness and tolerability of orlistat and liraglutide in patients with obesity in a real-world setting: The XENSOR Study. Gorgojo-Martínez JJ; Basagoiti-Carreño B; Sanz-Velasco A; Serrano-Moreno C; Almodóvar-Ruiz F Int J Clin Pract; 2019 Nov; 73(11):e13399. PubMed ID: 31397946 [TBL] [Abstract][Full Text] [Related]
13. Benefit-risk assessment of orlistat in the treatment of obesity. Sumithran P; Proietto J Drug Saf; 2014 Aug; 37(8):597-608. PubMed ID: 25064699 [TBL] [Abstract][Full Text] [Related]
14. Orlistat (Xenical) in the management of obesity. Cheah JS Ann Acad Med Singap; 2000 Jul; 29(4):419-20. PubMed ID: 11056767 [No Abstract] [Full Text] [Related]
15. [Does orlistat really offer help for the treatment of obesity?]. Orozco P Aten Primaria; 1999 Nov; 24(8):445-6. PubMed ID: 10630025 [No Abstract] [Full Text] [Related]
16. Outdated and misleading review of orlistat. Van R; Walt L Can Fam Physician; 1999 Dec; 45():2849-50, 2852. PubMed ID: 10626048 [No Abstract] [Full Text] [Related]
17. Pharmacological Treatment for Obesity in Adults: An Umbrella Review. Khalil H; Ellwood L; Lord H; Fernandez R Ann Pharmacother; 2020 Jul; 54(7):691-705. PubMed ID: 31958967 [No Abstract] [Full Text] [Related]
19. Recent advancements in drug treatment of obesity. Carter R; Mouralidarane A; Ray S; Soeda J; Oben J Clin Med (Lond); 2012 Oct; 12(5):456-60. PubMed ID: 23101148 [TBL] [Abstract][Full Text] [Related]
20. Spotlight on orlistat in the management of patients with obesity. Curran MP; Scott LJ Treat Endocrinol; 2005; 4(2):127-9. PubMed ID: 15783249 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]